维普中文期刊产品整合服务
135篇 您的检索式:作者名="Van Der Meijden AP"
    题名 作者 年代 出处 被引量
1A single immedi-ate postoperative instillation of chemotherapy decreases the risk of re-currence in patients with stage Ta T1 bladder cancer:a meta-analysis of published results of randomized clinical trials显示文摘Sylvester RJ Oosterlinck W van der Meijden AP 0,,6:1
2Predicting recurrence and progression in individual patients with stage Ta T1 bladder caocer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials 显示文摘Sylvester RJ van der Meijden AP Oosterlinck W 2006Eur Urol2006,49,:1
3Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables:a combined analysis of 2596 patients from seven EORTC trials 显示文摘Sylvester RJ van der Meijden AP OosterLinck W 2006Eur UroL2006,49,3:1
4Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with su- perficial bladder cancer: a meta -analysis of the published results of randomized clinical trials 显示文摘Sylvester RJ van der Meijden AP Lamn DL 2002J Urol2002,168,5:1
5A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with Ta T1 bladder eaneer:a meta-analysis of published results of randomized clinical trials 显示文摘Sylvester RJ Oosterlinek W van der Meijden AP 2004J Urol2004,171,61:1
6Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials 显示文摘Sylvester RJ van der Meijden AP Oosterlinck W 2006Eur Urol2006,49,3:1
7Pre- dicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables : a com- bined analysis of 2596 patients from seven EORTC trials显示文摘Sylvester RJ Van der Meijden AP Oostedinck W 2006Eur Urol2006,49,3:1
8Intravesical instillation of epirubicin, bacillus Calmette - Guerin plus is oniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder : a European Organization for Research and Treatment of Cancer genitor - urinary group randomized phase III trial 显示文摘Van der Meijden AP Brausi M Zambon V 2001J Urol2001,166,:1
9Predicting recurrence and progression in individual patients with stage Ta T 1 b- ladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials显示文摘Sylvester ILl van der Meijden AP Oosterlinck W 2006Eur Urol2006,49,:1
10Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trtals显示文摘Sylvester Rj van der Meijden AP Oosterlinck W 2006Eur Ural2006,49,3:1
11Predicting recurrence and progression in individual pa- tients with stage Ta T1 bladder cancer using EORTC risk ta- bles: a combined analysis of 2596 patients from seven EORTC trials显示文摘SYLVESTER RJ VAN DER MEIJDEN AP OOSTERLINCK W 2006Eur Urol2006,49,3:1
12EAU guidenlines on diagnosis and treatment of upper urinary tract transitional cell carcinoma显示文摘Oosterlinck W Solsona E van der Meijden AP 2004Eur Urol2004,46,2:1
13A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials显示文摘Sylvester RJ Oosterlinck W van der Meijden AP 2004J Urol2004,171,21:1
14Predic- ting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trims显示文摘Sylvester RJ van der Meijden AP Oosterlinck W 2006Eur Urol2006,9,3:1
15EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma显示文摘Oosterlinck W Solsona E van der Meijden AP 2004Eur Urol2004,46,2:1
16Predicting recurrence and progression in individual patients with stage Ta,T1 bladder cancer using EORTC risk tables显示文摘Sylvester RJ Van der Meijden AP Oosterlinck W 2006Eur Urol2006,49,:1
17Predicting recurrence and progression in individual patients with stage Ta T1 bladder caner using EORTC risk tables : a combined analysis of 2 596 patients from seven EORTC trials 显示文摘Sylvester RJ Van Der Meijden AP Oosterlinck W 2006Eur Urol2006,49,3:1
18EAU guideline on Ta/T1(non-muscle-invasive)bladder cancer显示文摘Oosterlinck W Van der Meijden AP Sylvester R 2008Eur Urol2008,120,:1
19Predicting recurrence and progression in individual patients with stage Ta Tl bladder cancer using EORTC risk tables:a combined analysis of 2596 patients from seven EORTC trials显示文摘Sylvester RJ van der Meijden AP Oosterlinck W 2006Eur Urol2006,49,:1
20EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ显示文摘van der Meijden AP Sylvester R Oosterlinek W 2005Eur Urol2005,48,3:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费